연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
1371. Mycobacterium yongonense sp. nov., a slow-growing non-chromogenic species closely related to Mycobacterium intracellulare.
Kim BJ1, Math RK, Jeon CO, Yu HK, Park YG, Kook YH, Kim BJ.
Int J Syst Evol Microbiol. 2013 Jan;63(Pt 1):192-9. doi: 10.1099/ijs.0.037465-0. Epub 2012 Mar 16.
Link
1370. Naturally occurring mutations in large surface genes related to occult infection of hepatitis B virus genotype C.
Kim H1, Lee SA, Kim DW, Lee SH, Kim BJ.
PLoS One. 2013;8(1):e54486. doi: 10.1371/journal.pone.0054486. Epub 2013 Jan 18.
Link
1369. Molecular evidence of lateral gene transfer in rpoB gene of Mycobacterium yongonense strains via multilocus sequence analysis.
Kim BJ1, Hong SH, Kook YH, Kim BJ.
PLoS One. 2013;8(1):e51846. doi: 10.1371/journal.pone.0051846. Epub 2013 Jan 31.
Link
1368. Heat shock protein-mediated cell penetration and cytosolic delivery of macromolecules by a telomerase-derived peptide vaccine.
Lee SA1, Kim BR, Kim BK, Kim DW, Shon WJ, Lee NR, Inn KS, Kim BJ.
Biomaterials. 2013 Oct;34(30):7495-505. doi: 10.1016/j.biomaterials.2013.06.015. Epub 2013 Jul 1.
Link
1367. Male-specific W4P/R mutation in the pre-S1 region of hepatitis B virus, increasing the risk of progression of liver diseases in chronic patients.
Lee SA1,?Kim KJ,?Kim DW,?Kim BJ.
J Clin Microbiol. 2013 Dec;51(12):3928-36. doi: 10.1128/JCM.01505-13. Epub 2013 Sep 11.
Link
1366. Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy.
Keam B1, Im SA, Koh Y, Han SW, Oh DY, Cho N, Kim JH, Han W, Kang KW, Moon WK, Kim TY, Park IA, Noh DY, Chung JK, Bang YJ.
Breast Cancer. 2013 Apr;20(2):167-73. doi: 10.1007/s12282-011-0323-0. Epub 2012 Feb 7.
Link
1365. Clinical usefulness of AJCC response criteria for neoadjuvant chemotherapy in breast cancer.
Keam B1, Im SA, Lim Y, Han SW, Moon HG, Oh DY, Cho N, Lee SH, Han W, Moon WK, Kim DW, Kim TY, Park IA, Noh DY.
Ann Surg Oncol. 2013 Jul;20(7):2242-9. doi: 10.1245/s10434-012-2756-x. Epub 2013 Mar 26.
Link
1364. Clinical outcomes of radiation-based locoregional therapy in locally advanced head and neck squamous cell carcinoma patients not responding to induction chemotherapy.
Lim Y1, Keam B, Koh Y, Kim TM, Lee SH, Hah JH, Kwon TK, Kim DW, Wu HG, Sung MW, Heo DS, Kim KH.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jul;116(1):55-60. doi: 10.1016/j.oooo.2013.02.007. Epub 2013 Apr 6.
Link
1363. Erlotinib versus gefitinib for control of leptomeningeal carcinomatosis in non-small-cell lung cancer.
Lee E1, Keam B, Kim DW, Kim TM, Lee SH, Chung DH, Heo DS.
J Thorac Oncol. 2013 Aug;8(8):1069-74. doi: 10.1097/JTO.0b013e318294c8e8.
Link
1362. Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer.
Keam B1, Kim DW, Park JH, Lee JO, Kim TM, Lee SH, Chung DH, Heo DS.
Int J Clin Oncol. 2013 Aug 6. [Epub ahead of print]
Link